[No standalone website (unbranded, no questionnaire)] A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)

How to apply

Determine if a study site for this clinical trial is near you. Contact the study to apply.

Find a Study Site

Study’s contact

Call center

please email:

Email address

Clinical.Trials@bms.com

Condition

Autoimmune Disorder,Primary Sjögren's Syndrome,Rheumatoid Arthritis,Systemic Lupus Erythematosus

Treatment type

Interventional

Investigational product

abatacept

Phase

Phase 2

Sponsor

Bristol-Myers Squibb

ClinicalTrials.gov identifier

NCT04186871

Study number

IM014029

Understanding clinical trials

Get answers to your questions about clinical trials.

About the study

Study to evaluate the safety and effectiveness of treatment with branebrutinib treatment in participants with active systemic Lupus Erythematosus (SLE) or Primary Sjögren's Syndrome (pSS), or branebrutinib treatment followed by open-label abatacept treatment in study participants with active Rheumatoid Arthritis (RA)

Who can take part?

You may be eligible to participate in the study if you meet the following criteria:

Inclusion criteria
  1. SLE) - Active SLE as defined by the Systemic Lupus Erythematosus International Collaborating Clinics (
  2. SLICC) classification - Diagnosed with SLE more than 24 weeks before screening visit Sub-study for primary Sjögren's Syndrome (
  3. pSS) - Moderate to severe pSS, meeting ACR-EULAR classification criteria Sub-study for active Rheumatoid Arthritis (
  4. RA) - Moderate to severe adult-onset RA - ACR global functional status class I to III Women and men must agree to follow instructions for methods of contraception.
Exclusion criteria
  1. RA) - Diagnosis with juvenile arthritis or idiopathic arthritis before age 16 For all sub-studies: - History of any significant drug allergy - Active infection, significant concurrent medical condition, or clinically significant abnormalities Other protocol defined inclusion/exclusion criteria could apply

For a full list of inclusion/exclusion criteria, please visit ClinicalTrials.gov

Study locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to apply

Determine if a study site for this clinical trial is near you. Contact the study to apply.

Find a Study Site